Form 4 Tracker
Eric Venker

Director, Chief Executive Officer; President & Immunovant CEO · 8 filings · Latest: Jun 24, 2026

Immunovant, Inc.
Roivant Sciences Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ROIV
Eric VenkerPresident & Immunovant CEOJun 24, 2026
Sale
$33.16200,000$6.6M1,613,063
ROIV
Eric VenkerPresident & Immunovant CEOJun 24, 2026
Option Exercise
$3.85200,000$770.0K1,813,063
ROIV
Venker EricJun 24, 2026
Proposed Sale
$33.16200,000$6.6M
ROIV
Eric VenkerPresident & Immunovant CEOMay 22, 2026
Sale
$30.27200,000$6.1M1,613,063
ROIV
Eric VenkerPresident & Immunovant CEOMay 22, 2026
Option Exercise
$3.85200,000$770.0K1,813,063
ROIV
Venker EricMay 22, 2026
Proposed Sale
$30.27200,000$6.1M
ROIV
Eric VenkerPresident & Immunovant CEOApr 20, 2026
Sale
$29.59200,000$5.9M1,647,546
ROIV
Eric VenkerPresident & Immunovant CEOApr 20, 2026
Option Exercise
$3.85200,000$770.0K1,847,546
ROIV
Venker EricApr 20, 2026
Proposed Sale
$29.59200,000$5.9M
IMVT
Eric VenkerDirector, Chief Executive OfficerApr 2, 2026
Sale
$24.1014,229$342.9K19,561
IMVT
Eric VenkerDirector, Chief Executive OfficerApr 1, 2026
Option Exercise
$14.46368,750$5.3M368,750
ROIV
Eric VenkerPresident & Immunovant CEOMar 17, 2026
Sale
$28.24200,000$5.6M1,647,546
ROIV
Eric VenkerPresident & Immunovant CEOMar 17, 2026
Option Exercise
$3.85200,000$770.0K1,847,546
ROIV
Venker EricMar 17, 2026
Proposed Sale
$28.24200,000$5.6M
ROIV
Eric VenkerPresident & Immunovant CEOFeb 13, 2026
Sale
$26.49200,000$5.3M1,654,597
ROIV
Eric VenkerPresident & Immunovant CEOFeb 13, 2026
Option Exercise
$3.85200,000$770.0K1,854,597
ROIV
Venker EricFeb 13, 2026
Proposed Sale
$26.49200,000$5.3M
ROIV
Venker EricJan 12, 2026
Proposed Sale
$21.92200,000$4.4M
ROIV
ERIC VENKERDec 24, 2025
Proposed Sale
$22.5375,000$1.7M
ROIV
ERIC VENKERDec 23, 2025
Proposed Sale
$22.45200,000$4.5M

Page 1 of 3

Next →